Course: Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic
CME Credits: 1.00
Released: 2022-10-27
The COVID-19 pandemic affected cancer treatment in the context of usual care and clinical trials. Clinical trial activity and routine care were disrupted, allowing for limited new enrollments early in the pandemic.- The proportion of remote visits and delayed nonessential surgeries or systemic therapies increased. Trials were prioritized based on disease severity and resource allocation.
Educational Objective
To identify the key insights or developments described in this article
View Full Course